Related Experiment Video
Updated: Aug 30, 2025

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series
Adrian M Chye1,2,3,4, Ina I C Nordman1,5, Aaron L Sverdlov1,5,6,7
1Calvary Mater Newcastle, Newcastle, NSW, Australia.
Pericardial diseases secondary to immune checkpoint inhibitors (ICI) are rare. Here, we describe two cases of immune-related pericarditis caused by ICI for treatment of advanced NSCLC. Select patients can be successfully rechallenged with ICI after immune-related pericardial disease.
Pericardial diseases secondary to immune checkpoint inhibitors (ICI) are rare. Here, we describe two cases of immune-related pericarditis caused by ICI for treatment of advanced NSCLC. Select patients can be successfully rechallenged with ICI after immune-related pericardial disease.
Related Concept Videos
Pericarditis III: Medical Management
Pericarditis I: Introduction
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Pericarditis IV: Nursing Management
Endocarditis III: Medical Management

